BSHC
VRTX icon

Breed's Hill Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Breed's Hill Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$558K Buy
1,253
+27
+2% +$12.4K 0.27% 58
2025
Q1 		$594K Sell
1,226
-10
-0.8% -$4.66K 0.32% 48
2024
Q4 		$498K Buy
+1,236
New +$573K 0.26% 64

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Breed's Hill Capital's VRTX Position: Q2 2025 in Review

Breed's Hill Capital increased its Vertex Pharmaceuticals (VRTX) stake by 2.2% in Q2 2025, buying an estimated $12.4K and bringing the position to 1,253 shares worth $558K. The position accounts for 0.27% of the portfolio, ranked #58.

Breed's Hill Capital first reported a position in VRTX in Q4 2024 and has held it in 3 quarters since. The position peaked at $594K in Q1 2025. 1,562 funds tracked by Wall St. Rank hold VRTX as of Q2 2025.

  • Breed's Hill Capital held 1,253 shares of Vertex Pharmaceuticals worth $558K as of Q2 2025.
  • Breed's Hill Capital bought 27 Vertex Pharmaceuticals shares in Q2 2025, an estimated $12.4K.
  • Vertex Pharmaceuticals made up 0.27% of Breed's Hill Capital's portfolio in Q2 2025, its #58 holding.
  • Breed's Hill Capital first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • Breed's Hill Capital's Vertex Pharmaceuticals position peaked at $594K in Q1 2025.
  • 1,562 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2025.

Based on Breed's Hill Capital's 13F filing for Q2 2025, filed 8 Aug 2025.